JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Acampa, W.
Right arrow Articles by Cuocolo, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Acampa, W.
Right arrow Articles by Cuocolo, A.

Prognostic Value of Myocardial Ischemia in Patients with Uncomplicated Acute Myocardial Infarction: Direct Comparison of Stress Echocardiography and Myocardial Perfusion Imaging

Wanda Acampa, MD, PhD1,2,3, Letizia Spinelli, MD4, Mario Petretta, MD4, Francesco De Lauro, MD1, Francesco Ibello, MD1 and Alberto Cuocolo, MD1,2,3

1 Department of Biomorphological and Functional Sciences, University Federico II, Napoli, Italy
2 Institute of Biostructure and Bioimages of the National Council of Research, Napoli, Italy
3 Neuromed, Pozzilli, Italy
4 Department of Clinical Medicine, Cardiovascular and Immunological Sciences, University Federico II, Napoli, Italy



View larger version (15K):

[in a new window]
 
FIGURE 1. Concordance between myocardial perfusion SPECT and DSE for classification of patients as nonischemic or ischemic.

 


View larger version (10K):

[in a new window]
 
FIGURE 2. Event-free survival curves by Kaplan–Meier analysis in patients without or with ischemia at myocardial perfusion SPECT. Numbers of patients available for follow-up at 0, 10, 20, 30, 40, 50, and 60 mo were, respectively, 39, 39, 38, 31, 29, 17, and 10; and 55, 51, 42, 33, 26, 22, and 11.

 


View larger version (13K):

[in a new window]
 
FIGURE 3. Event-free survival curves by Kaplan–Meier analysis in patients without ischemia and in those with mild or moderate-to-severe ischemia at myocardial perfusion SPECT. Numbers of patients available for follow-up at 0, 10, 20, 30, 40, 50, and 60 mo were, respectively, 39, 39, 38, 31, 29, 17, and 10; 34, 31, 28, 19, 18, 14, and 5; and 21, 20, 14, 14, 8, 8, and 6. Mod-sev = moderate to severe.

 


View larger version (10K):

[in a new window]
 
FIGURE 4. Event-free survival curves by Kaplan–Meier analysis in patients without or with myocardial ischemia at DSE. Numbers of patients available for follow-up at 0, 10, 20, 30, 40, 50, and 60 mo were, respectively, 31, 30, 26, 19, 18, 11, and 4; and 63, 60, 54, 45, 37, 28, and 17. NS = not significant.

 


View larger version (10K):

[in a new window]
 
FIGURE 5. Event-free survival curves by Kaplan–Meier analysis in patients with worsening or biphasic patterns at DSE. Numbers of patients available for follow-up at 0, 10, 20, 30, 40, 50, and 60 mo were, respectively, 47, 45, 45, 36, 31, 24, and 13; and 16, 15, 9, 9, 6, 4, and 4.

 


View larger version (7K):

[in a new window]
 
FIGURE 6. Incremental prognostic value for cardiac events (global {chi}2 values on y-axis) obtained considering in hierarchical order: clinical data; clinical data and left ventricular ejection fraction (LVEF); clinical data, LVEF, and DSE; clinical data, LVEF, DSE, and SPECT. NS = not significant.

 


View larger version (12K):

[in a new window]
 
FIGURE 7. Event-free survival curves by Kaplan–Meier analysis in patients with ischemia and discordant results between myocardial perfusion DSE and SPECT. Numbers of patients available for follow-up at 0, 10, 20, 30, 40, 50, and 60 mo were, respectively, 17, 17, 17, 15, 14, 9, and 6; and 9, 8, 5, 3, 3, 3, and 0.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2005 by the Society of Nuclear Medicine.